Genentech, Biogen appeal US judgement favouring GSKin anti-CD20 Mab infringement suit
07 December 2011
Nancy Faigen
Please Login to read the full article.
07 December 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Genmab simplified protocol brings ofatumumab filing in lymphoma forward a year
- Genmab and GSK file for Japanese approval of ofatumumab in CLL
- Positive Phase II lymphoma data for Genmab/GSK's ofatumumab
- Mylan loses bid to have US Teva patent infringement suit on Copaxone tossed out
COMMENT
Other Informa Comment
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
